Broker’s call: Dr Lal Pathlabs (Buy)
Target: ₹3,400 CMP: ₹3,053.50 Dr Lal Pathlabs’ (DLPL) Q2-FY25 margins expanded by 110bps y-o-y on the back of improving contribution
Continue reading
Tag: Dr Lal PathLabs
Dr. Lal PathLabs Q4 results: Net profit rises 49% on healthy testing demand
Analysts expect Indian diagnostic firms to benefit from geographic expansions and price hikes. 1 min read Last Updated : May
Continue reading